UPMC Selects Oracle to Power Enterprise Healthcare Analytics Initiative

UPMC Selects Oracle to Power Enterprise Healthcare Analytics Initiative
Oracle to Provide Expertise and Solutions to Help UPMC Analyze Clinical, Genomic, Administrative and Financial Data to Support Accountable Care and Personalized Medicine

ORACLE OPENWORLD, San Francisco – October 1, 2012

UPMC, a $10 billion integrated global health enterprise headquartered in Pittsburgh, has selected Oracle Health Sciences applications and Oracle technology and hardware as a key part of the foundation for its new five-year, $100 million enterprise healthcare analytics initiative.

Oracle solutions will power the groundbreaking enterprise analytics initiative that will bring together data ‒ including clinical, genomic, financial, administrative and operational information ‒ from more than 200 sources from within UPMC, its health plan and other entities to drive truly personalized care that will yield better patient outcomes.

Using Oracle's advanced analytical and predictive modeling solutions that put new insight into the hands of clinicians, researchers and business managers, UPMC looks to achieve better patient outcomes, advance research and continually improve the quality of patient care while reducing costs.

Early projects will focus on improving quality reporting and measurement across the health network, extending insight into the effectiveness of specific treatments and cost variations and improving disease prevention through predictive alerts.
To achieve its goals, the nationally acclaimed health system will deploy a wide range of Oracle solutions, including Oracle Health Sciences applications such as Oracle Enterprise Healthcare Analytics, Oracle Health Sciences Network. UPMC will also implement Oracle Fusion Analytics, as well as multiple components of Oracle Fusion Middleware, such as Oracle Hyperion Profitability and Cost Management to support cost-based accounting and Oracle Identity and Access Management Suite Plus to help ensure regulatory compliance and protect sensitive information.

UPMC chose Oracle Exadata Database Machine as the hardware foundation for its analytical environment over competitive offerings because Oracle applications and technology are optimized to run on the engineered system – yielding unmatched scalability, performance and return on investment.

UPMC will build the analytical environment over the next two years to support the health system's new Center for Innovative Science.

Terms of UPMC's agreement with Oracle were not disclosed. The $100 million project includes a variety of hardware, software, training and other personnel costs.

Supporting Quotes
"Today's healthcare institutions have access to unprecedented types and volumes of data that have the potential to unlock the secrets of human health and disease leading to new and highly personalized care pathways. In this environment, advanced information management and analytics platforms will fuel the next giant leap forward for healthcare, in much the same way that the microscope and antibiotics transformed care in generations past. With Oracle technology and Oracle Health Sciences Enterprise Healthcare Analytics, we will create a new foundation for insight that supports personalized, accountable care and accelerates the translation of scientific advances in care," said Dr. Steven D. Shapiro, chief medical and scientific officer, UPMC.
"UPMC's complex technology infrastructure requires a robust, highly-scalable and secure IT platform – as well as a pre-built data model and powerful, yet user-friendly analytical applications – to put real-time insight into the hands of our clinicians, researchers and administrators," said Lisa Khorey, vice president of enterprise systems and data management, UPMC.
"By leveraging Oracle's integrated health sciences applications and complete technology stack, UPMC will gain expanded insight into clinical, research and operational domains – all of which are critical to the delivery of personalized and cost-effective care," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "We are excited to provide the foundation for UPMC's enterprise healthcare analytics initiative, which has the potential to truly transform patient care, cost and outcomes."

Supporting Resources

Oracle in Health Sciences

Press Release: UPMC Fosters 'Personalized Medicine' with $100 Million Investment in Sophisticated Data Warehouse and Analytics

Video: Personalized Medicine at UPMC

Press Release: Oracle Unveils Oracle Health Sciences Network

Follow Oracle Health Sciences on Twitter

Join the Oracle Health Sciences Community on Facebook

Oracle Health Sciences on YouTube

Oracle OpenWorld 2012

Oracle OpenWorld 2012 Keynotes

Like Oracle OpenWorld on Facebook

Follow Oracle OpenWorld on Twitter

Oracle OpenWorld Blog

Oracle OpenWorld on LinkedIn


Oracle engineers hardware and software to work together in the cloud and in your data center.  For more information about Oracle (NASDAQ:ORCL), visit www.oracle.com.
About Oracle in Industries

Oracle industry solutions leverage the company's best-in-class portfolio of products to address complex business processes relevant to healthcare, helping speed time to market, reduce costs, and gain a competitive edge.
About Oracle OpenWorld

Oracle OpenWorld San Francisco is the most important educational and networking event of the year for Oracle technologists, customers, and partners. This information technology event is dedicated to helping businesses optimize existing systems and understand upcoming technology breakthroughs. The conference, which draws more than 50,000 attendees from over 140 countries, offers more than 2,100 educational sessions, 400 product demos, exhibitions from 450 partners and customers showcasing applications, middleware, database, server and storage systems, industries, management and infrastructure – all engineered for innovation. Oracle OpenWorld 2012 is being held September 30-October 4 at The Moscone Center in San Francisco. For more information please visit www.oracle.com/openworld. Watch Oracle OpenWorld keynotes, sessions and more live on YouTube. Join the Oracle OpenWorld discussion on Twitter, Facebook and the Oracle OpenWorld Blog.

Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.
Contact Info

Greg Lunsford
[email protected]

Mary Tobin
O'Keeffe & Company
[email protected]

Wendy Zellner
[email protected]

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.